This study further confirmed the potential therapeutic effects of regulating CX3CR1/L1 signaling to prevent cognitive impairment in POCD, via modulation of persistent pain and inflammatory response, as well as GABA signaling, by regulating astrocyte activation. This evidence concerns the gene CX3CR1 and Cognitive impairment.